Same Indication

Pembrolizumab vs Valsartan

Pembrolizumab vs Valsartan: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Valsartan.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Valsartan: Angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Valsartan — 6 hours.

Chemical Properties

Molecular Formula: Valsartan — C24H29N5O3.

Molecular Weight: Valsartan — 435.5190 g/mol.

Type: Pembrolizumab — Antibody; Valsartan — Small molecule.